openPR Logo
Press release

Global 3D Printed Drugs Market (2018-2025)-GMI Research

10-15-2018 09:20 AM CET | Health & Medicine

Press release from: GMI Research

Global 3D Printed Drugs Market (2018-2025)-GMI Research

Global 3D Printed Drugs Market (2018-2025)-GMI Research

Global 3D Printed Drugs Market by Technology Type (Fused Deposition Modelling, Inkjet Printing, and others) and by Geography – Opportunities & Forecast 2018-2025

Since 1990’s, 3D printing technology is being used by the medical device industry and recently, it has started penetrating into the pharmaceutical industry. The pharmaceutical industry is utilizing 3D printing for manufacturing drugs. The first 3D printed drug was approved in 2015 by the Food and Drug Administration (FDA), since, then there has been a growing investment in 3D printing drugs from drug manufacturers. The 3D printed drugs are easy to swallow and can be customized according to color, and structure. Spritam was the first drug which got approved by FDA for onset seizures and myoclonic seizers in 2015 and in the same year, it was introduced by Aprecia Pharmaceuticals in the US. The 3D printed drugs can be manufactured only if the FDA passes a priority review voucher for the proposed drugs.

Download Sample Brochure : https://www.gmiresearch.com/sample-research-report.php?rid=142

The major factors that are propelling the growth of the 3D printed drugs are technological innovations in 3D printing procedures, user-friendly and easy availability. In addition, it is expected that in the coming years, the ability to print drugs on-demand would reduce the 3D printed drug cost, lower the risk of counterfeiting and would be able to deliver the personalize drug to individual patients i.e. catering the needs of the patient. Further, one of the key factors resulting in the high demand for 3D printed drugs is their instant solubility. 3D printed drugs are easy to swallow, thus, are being used for epilepsy patients, aged population and infants.

Various players and universities operating in the 3D printed drugs market include 3D Printer Drug Machine, Aprecia Pharmaceuticals, FabRx Ltd, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, National University of Singapore, The University of Nottingham, UCL School of Pharmacy, University College of London, University of Glasgow and others

The global 3D printed drugs market has been segmented based on technology type and key geographies. Based on technology type, the market comprises of fused deposition modelling, inkjet printing, and others. This research report on 3D printed drugs market provides in-depth analysis of the global 3D printed drugs market based on technique type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for 3D printed drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent development in the market.

Key questions answered in this research report:
1- At what pace is 3D printed drugs market growing? What will be the growth trend in the future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the 3D printed drugs market?
4- What are the various application areas and how they are poised to grow?

The global 3D printed drugs market is segmented based on technology type and geography:
Global 3D Printed Drugs Market by Technology Type
• Fused Deposition Modelling
• Inkjet Printer
• Others
Global 3D Printed Drugs Market by Geography
• North America
• Asia-Pacific
• Europe
• Rest of World
Global 3D Printed Drugs Market Competitive Landscape
• Major Players and their Key Strategies
• New product launches
• Mergers and acquisitions
• Collaborations, partnerships, agreements and joint venture
Geography
• North America
As a part of customization
o By Technology Type
o United States
o Canada
o Mexico
• Europe
As a part of customization
o By Technology Type
o United Kingdom
o Germany
o Spain
o Rest of Europe
• Asia-Pacific
As a part of customization
o By Technology Type
o China
o Australia
o India
o Rest of Asia-Pacific
• Rest of the World
As a part of customization
o By Technology Type
o Brazil
o South Africa
o GCC countries
o Rest of the world (remaining countries of the LAMEA region)
Leading Market Players
• 3D Printer Drug Machine
• Aprecia Pharmaceuticals
• FabRx Ltd.
• GlaxoSmithKline Plc.
• Hewlett Packward Caribe, BV, LLC
• National University of Singapore
• The University of Nottingham.
• UCL School of Pharmacy
• University College of London
• University of Glasgow

Buy Report @ https://www.gmiresearch.com/buy-research-report.php?rid=142&licence=singaluser

Table of Content (TOC)

• Executive Summary
• Introduction
• Study Objectives
• Market Definition
• Market Covered
• Geographical Coverage
• Study Years & Currency
• Market Stakeholders
• Key Questions this Study will Answer
• GMI Research’s Approach & Methodology
• Global 3D Printed Drugs Market- Overview
• Introduction `
• Market Segmentation
• Value Chain Analysis
• Drivers
• Restraints
• Trends
• Global 3D Printed Drugs Market Revenue Forecast till 2025
• Global 3D Printed Drugs Market by Technology Type Revenue Forecast till 2025
• Fused Deposition Modelling
• Inkjet Printing
• Others
• Global 3D Printed Drugs Market by Geography Revenue Forecast till 2025
• North America 3D Printed Drugs Market Revenue Forecast till 2025
• North America 3D Printed Drugs Market by Technology Type (Option 1: 25% customization)
• Fused Deposition Modelling
• Inkjet Printing
• Others
• Europe 3D Printed Drugs Market Revenue Forecast till 2025
• Europe 3D Printed Drugs Market by Technology Type (Option 2: 25% customization)
• Fused Deposition Modelling
• Inkjet Printing
• Others
• Asia-Pacific 3D Printed Drugs Revenue Forecast till 2025
• Asia-Pacific 3D Printed Drugs Market by Technology Type (Option 3: 25% customization)
• Fused Deposition Modelling
• Inkjet Printing
• Others
• Rest of the World 3D Printed Drugs Market Revenue Forecast till 2025
• Rest of the World 3D Printed Drugs Market by Technology Type (Option 4: 25% customization)
• Fused Deposition Modelling
• Inkjet Printing
• Others
• Competitive Landscape
• Industry Attractiveness
• Porter 5 Analysis
• Major players and their key strategies
• Company Share Analysis
• Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
• 3D Printer Drug Machine
• Company Overview
• Financials
• Recent Developments
• Aprecia Pharmaceuticals
• Company Overview
• Financials
• Recent Developments
• FabRx Ltd.
• Company Overview
• Financials
• Recent Developments
• GlaxoSmithKline Plc.
• Company Overview
• Financials
• Recent Developments
• Hewlett Packard Caribe, BV, LLC
• Company Overview
• Financials
• Recent Developments
• National University of Singapore
• Company Overview
• *Research and Development Projects and Spending’s
• Recent Developments
• The University of Nottingham.
• Company Overview
• Research and Development Projects and Spending’s
• Recent Developments
• UCL School of Pharmacy
• Company Overview
• Research and Development Projects and Spending’s
• Recent Developments
• University College of London
• Company Overview
• Research and Development Projects and Spending’s
• Recent Developments
• University of Glasgow
• Company Overview
• Research and Development Projects and Spending’s
• Recent Developments

• About GMI Research

For Sample Pages & Detailed Report Description Visit : https://www.gmiresearch.com/report/global-3d-printed-drugs-market-opportunities-forecast-share-technology-type-insights-company-profile.html

* Research and Development Projects and Spending’s are subjected to the availability of the information on the secondary domain and further, to the insights shared by the primary respondents

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: sales@gmiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global 3D Printed Drugs Market (2018-2025)-GMI Research here

News-ID: 1301763 • Views: 212

More Releases from GMI Research

Pharmaceutical Logistics Market reached USD 69.3 billion in 2021, and expected t …
Global Pharmaceutical Logistics Market was estimated USD 69.3 billion in 2021, and is expected to reach USD 111.3 billion in 2029, and the market is estimated to grow at a robust CAGR of 6.1% during 2022-2029 For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/pharmaceutical-logistics-market-analysis-industry-research/ The factors driving the growth of Pharmaceutical Logistics Market includes increase in the production of vaccines and medicines, rise in the sales of generic drugs, growing
Specialty Fats & Oils Market is expected to reach USD 22.0 billion in 2029, from …
The Specialty Fats & Oils Market generated a revenue of USD 13.1 billion in 2021 and is expected to reach USD 22.0 billion in 2029, expanding at a CAGR of 6.7% during the forecast period. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/specialty-fats-andoils-market-analysis-industry-research/ The factors driving the growth of Specialty Fats & Oils Market includes growing demand for natural cosmetic products, rise in the production of cocoa around the world,
Telecom Services Market is projected to touch USD 2.6 billion in 2029, registeri …
Telecom Services Market size reached USD 1.7 billion in 2021 and is estimated to reach USD 2.6 billion in 2029 and the market is estimated to grow at a CAGR of 5.9% from 2022-2029 For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/telecom-services-market-analysis-industry-research/ The factors driving the growth of Telecom Services Market includes increasing penetration of smartphone devices, rising demand for high-speed data connectivity and value-added managed services, commercialization of 5G
Plant Extracts Market is Predicted to Expand at a significant CAGR of 11.3% duri …
Plant Extracts Market is slated to register a CAGR of 11.3% over the forecast period, till 2029. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/plant-extracts-market/ The factors driving the growth of Plant Extracts Market includes increasing application of essential oils in food and beverages, cosmetic and cleaning products, rising awareness about the health benefits offered by herbal extracts, growing prevalence of diabetes and heart related diseases and improvements in the

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug